Showing results (161-170 of 187) with videos related to
Sort By:
Pageof 19
Blood|October 26, 2023
CAR T cells and time-limited ibrutinib as treatment for relapsed/refractory mantle cell lymphoma: the phase 2 TARMAC studyAdrian Minson, Nada Hamad, Chan Y Cheah, et al.Molecular Oncology|November 18, 2025
European Code Against Cancer, 5th edition - hormone replacement therapy, other common medical therapies and cancerMangesh A Thorat, Marc Arbyn, David Baldwin, et al.Blood|September 24, 2024
Pretransplant MRD detection of fusion transcripts is strongly prognostic in KMT2A-rearranged acute myeloid leukemiaSun Loo, Nicola Potter, Adam Ivey, et al.The Lancet. Haematology|July 1, 2022
[18F]FDG-PET-CT compared with CT for persistent or recurrent neutropenic fever in high-risk patients (PIPPIN): a multicentre, open-label, phase 3, randomised, controlled trialAbby Douglas, Karin Thursky, Timothy Spelman, et al.Haematologica|February 15, 2020
Utility of clinical comprehensive genomic characterization for diagnostic categorization in patients presenting with hypocellular bone marrow failure syndromesPiers Blombery, Lucy Fox, Georgina L Ryland, et al.Leukemia & Lymphoma|October 17, 2015
Double umbilical cord blood transplant is effective therapy for relapsed or refractory Hodgkin lymphomaPhilip A Thompson, Travis Perera, David Marin, et al.Blood Advances|July 12, 2022
Third-party CMV- and EBV-specific T-cells for first viral reactivation after allogeneic stem cell transplantWei Jiang, Leighton E Clancy, Selmir Avdic, et al.Frontiers in Public Health|October 15, 2025
Piloting a cancer awareness app across six European countries: a pre-post studyFurqan Ahmed, Silvana Melissa Romero Saletti, Erica D'Souza, et al.Molecular Oncology|January 16, 2026
European Code Against Cancer, 5th edition - organised cancer screening programmesEsther Toes-Zoutendijk, Marc Arbyn, Anssi Auvinen, et al.Internal Medicine Journal|May 3, 2025
Outcomes of allogeneic haemopoietic transplant for chronic lymphocytic leukaemia in the modern eraLuani Barge, Steven Tran, Glen Kennedy, et al.Pageof 19